IL2 and systemic lupus erythematosus: This results in DUSP-4-mediated STAT5 de-phosphorylation and imbalanced STAT3/STAT5 signaling, favoring IL-17A and reducing IL-2 expression, hallmarks of SLE T cells [128,144] (Fig. 1).